Free Trial

Oracle (NYSE:ORCL) Given New $250.00 Price Target at Guggenheim

Oracle logo with Computer and Technology background

Oracle (NYSE:ORCL - Get Free Report) had its price objective hoisted by investment analysts at Guggenheim from $220.00 to $250.00 in a research report issued on Wednesday. The brokerage currently has a "buy" rating on the enterprise software provider's stock. Guggenheim's target price would suggest a potential upside of 17.16% from the company's previous close.

ORCL has been the subject of several other research reports. Stephens began coverage on Oracle in a research report on Wednesday, March 19th. They issued an "equal weight" rating and a $167.00 target price for the company. The Goldman Sachs Group reiterated a "neutral" rating and issued a $195.00 price objective (up previously from $145.00) on shares of Oracle in a report on Friday, June 13th. JMP Securities set a $240.00 price target on shares of Oracle and gave the stock a "market outperform" rating in a research note on Thursday, June 12th. BMO Capital Markets raised shares of Oracle from a "market perform" rating to an "outperform" rating and raised their target price for the company from $200.00 to $235.00 in a research note on Friday, June 13th. Finally, Westpark Capital lifted their target price on shares of Oracle from $195.00 to $246.00 and gave the company a "buy" rating in a report on Thursday, June 12th. Eleven investment analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $195.39.

Read Our Latest Analysis on ORCL

Oracle Trading Up 2.5%

Shares of ORCL stock traded up $5.21 during trading hours on Wednesday, reaching $213.39. The company's stock had a trading volume of 5,753,695 shares, compared to its average volume of 9,785,916. The company has a current ratio of 0.75, a quick ratio of 1.02 and a debt-to-equity ratio of 4.07. Oracle has a one year low of $118.86 and a one year high of $216.60. The stock has a market capitalization of $596.84 billion, a P/E ratio of 49.18, a P/E/G ratio of 3.13 and a beta of 1.32. The firm's fifty day simple moving average is $155.97 and its 200 day simple moving average is $160.82.

Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The firm had revenue of $15.90 billion during the quarter, compared to analysts' expectations of $15.58 billion. During the same period last year, the company posted $1.63 EPS. The company's quarterly revenue was up 11.3% compared to the same quarter last year. Equities research analysts expect that Oracle will post 5 EPS for the current year.

Insider Buying and Selling

In other news, Director Leon E. Panetta sold 5,000 shares of the business's stock in a transaction dated Friday, April 11th. The shares were sold at an average price of $129.77, for a total value of $648,850.00. Following the completion of the sale, the director now owns 58,090 shares in the company, valued at approximately $7,538,339.30. The trade was a 7.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Naomi O. Seligman sold 2,000 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $145.81, for a total transaction of $291,620.00. Following the transaction, the director now owns 34,630 shares in the company, valued at approximately $5,049,400.30. This represents a 5.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 427,366 shares of company stock valued at $80,183,723 over the last quarter. 42.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Oracle

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in Oracle by 2.2% in the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider's stock worth $22,498,982,000 after acquiring an additional 3,513,464 shares in the last quarter. FMR LLC raised its position in shares of Oracle by 0.4% in the 4th quarter. FMR LLC now owns 38,002,902 shares of the enterprise software provider's stock valued at $6,332,803,000 after purchasing an additional 156,269 shares during the last quarter. Geode Capital Management LLC boosted its stake in Oracle by 1.8% in the 4th quarter. Geode Capital Management LLC now owns 35,814,302 shares of the enterprise software provider's stock worth $5,954,961,000 after purchasing an additional 619,619 shares in the last quarter. Franklin Resources Inc. grew its position in Oracle by 9.3% during the 4th quarter. Franklin Resources Inc. now owns 20,202,421 shares of the enterprise software provider's stock worth $3,366,531,000 after purchasing an additional 1,722,037 shares during the last quarter. Finally, Northern Trust Corp increased its stake in Oracle by 0.6% during the 1st quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider's stock valued at $2,760,048,000 after purchasing an additional 120,889 shares in the last quarter. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

About Oracle

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Analyst Recommendations for Oracle (NYSE:ORCL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oracle Right Now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
Google’s $32B Move: 3 Cybersecurity Stocks to Watch

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines